Aesica Pharmaceuticals appoints new chairman
Aesica Pharmaceuticals, the pharmaceutical contract manufacturer backed by Silverfleet Capital, the European private equity firm, has appointed David Greensmith as non-executive chairman. David has highly relevant experience from operating in the chemical and pharmaceutical markets, as well as through holding a number of private equity backed non-executive chairmanship positions. David’s
